Shares of Evoke plc (LON:EVOK – Get Free Report) traded down 10% during trading on Friday . The company traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). 65,066,164 shares were traded during trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on EVOK shares. Berenberg Bank reduced their target price on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a report on Wednesday, December 4th. Jefferies Financial Group restated a “buy” rating and issued a GBX 140 ($1.81) price objective on shares of Evoke in a report on Monday, December 16th.
View Our Latest Stock Report on Evoke
Evoke Stock Down 1.1 %
Evoke (LON:EVOK – Get Free Report) last announced its quarterly earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. As a group, sell-side analysts anticipate that Evoke plc will post 12.7648305 EPS for the current fiscal year.
Insider Transactions at Evoke
In other news, insider Andrea Gisle Joosen purchased 14,572 shares of the company’s stock in a transaction that occurred on Tuesday, January 28th. The shares were purchased at an average price of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). Company insiders own 27.00% of the company’s stock.
Evoke Company Profile
Recommended Stories
- Five stocks we like better than Evoke
- The Most Important Warren Buffett Stock for Investors: His Own
- MarketBeat Week in Review – 03/24 – 03/28
- How to Use Stock Screeners to Find Stocks
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Pros And Cons Of Monthly Dividend Stocks
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.